MPOX
Clinical trials for MPOX explained in plain language.
Never miss a new study
Get alerted when new MPOX trials appear
Sign up with your email to follow new studies for MPOX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive mpox vaccine trial launches in DRC to protect thousands
⭐️ VACCINE ⭐️ Not yet recruitingThis study will test the LC16m8 mpox vaccine in nearly 12,000 people aged 1 year and older in the Democratic Republic of Congo. The goal is to see if the vaccine is safe and provides strong protection against mpox. Participants will receive the vaccine and be monitored for side e…
Matched conditions: MPOX
Sponsor: International Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:57 UTC
-
Mpox vaccine immunity under the microscope: new study tracks protection
Knowledge-focused Not yet recruitingThis study will follow 300 adults in Kinshasa, DRC, who received either the MVA-BN or LC16m8 mpox vaccine as part of routine vaccination. Researchers will collect blood samples at several time points to measure how strong and long-lasting the immune response is. The goal is to be…
Matched conditions: MPOX
Phase: PHASE4 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated May 07, 2026 18:42 UTC